Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension

NCT04773028 is registered in ClinicalTrials.gov with AHMET ZENGIN as lead sponsor.

NCT NCT04773028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04773028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension
Lead sponsor
AHMET ZENGIN
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
May 4, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension